Shanghai INT Medical Instruments Co., Ltd. has announced the successful closing of a placing of 35,200,000 new H shares under a general mandate. The placement was conducted pursuant to a Placing Agreement, with all conditions fulfilled and completion taking place on January 22, 2026. The company's shares involved in this transaction have not been registered under the U.S. Securities Act and are not being offered or sold in the United States or in any other jurisdiction where such distribution would be unlawful.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Int Medical Instruments Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260122-11998227), on January 22, 2026, and is solely responsible for the information contained therein.
Comments